Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do bronchodilators have an effect on bronchiolitis?

Margrid Schindler1

  • 1Consultant, Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK. schinm@gosh.nhs.uk

Critical Care (London, England)
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.

Health technology assessment (Winchester, England)·2014
Same author

Control of hyperglycaemia in paediatric intensive care (CHiP): study protocol.

BMC pediatrics·2010
Same author

Surfactant for acute respiratory failure in children: where should it fit in our treatment algorithm?

Critical care (London, England)·2007
Same author

Base deficit is a poor indicator of tissue acidosis.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2004
Same journal

Correction: VExUS score: optimizing its use in perioperative and critical care management.

Critical care (London, England)·2026
Same journal

Optimizing β-lactam antibiotics with the highest concentration-for continuous infusion reduce carbon footprint in intensive care.

Critical care (London, England)·2026
Same journal

Physiological and clinical effects of selected airway clearance techniques in mechanically ventilated adult ICU patients: a systematic review and synthesis without meta-analysis.

Critical care (London, England)·2026
Same journal

How we use the neurological pupil index (NPi).

Critical care (London, England)·2026
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
See all related articles

Bronchodilators like albuterol do not effectively treat infant bronchiolitis, with most studies showing no benefit. Nebulized adrenaline, however, demonstrated significant clinical improvements in infants with this respiratory condition.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Clinical Trials

Background:

  • Bronchiolitis is a common respiratory infection in infants.
  • The efficacy of bronchodilators in treating bronchiolitis remains controversial.
  • Salbutamol, albuterol, and ipratropium bromide are commonly considered treatments.

Purpose of the Study:

  • To evaluate the effectiveness of bronchodilators and nebulized adrenaline in managing infant bronchiolitis.
  • To synthesize evidence from randomized controlled trials on these interventions.

Main Methods:

  • Systematic review and analysis of 12 randomized controlled trials (RCTs) for bronchodilators (salbutamol, albuterol, ipratropium bromide).
  • Analysis of 5 recent RCTs evaluating nebulized adrenaline (epinephrine).

Related Experiment Videos

  • Assessment of clinical outcomes including clinical scores, oxygen requirements, respiratory rate, wheeze, and pulmonary resistance.

    • Main Results:

    • Nine out of 12 trials (75%) found no significant effect of salbutamol/albuterol on bronchiolitis.
    • Ipratropium bromide showed no significant benefit.
    • All five trials on nebulized adrenaline reported significant clinical improvement, reduced oxygen needs, lower respiratory rates, and decreased wheezing.
    • Nebulized adrenaline also led to reduced hospital admissions and faster discharge in some studies.
    • Pulmonary resistance improved with adrenaline but not with salbutamol/albuterol.

    Conclusions:

    • Current evidence does not support the routine use of bronchodilators for infant bronchiolitis.
    • Nebulized adrenaline shows promising results and greater evidence of efficacy in improving clinical outcomes for bronchiolitis.
    • Further research may clarify the role of adrenaline in bronchiolitis management.